Evidence map›Paper›PMID 34112821›Full record

ArticleScientific reports2021

Smart material based on boron crosslinked polymers with potential applications in cancer radiation therapy.

José Vedelago, Facundo Mattea, Sebastián Triviño, María Del Mar Montesinos, Walter Keil, Mauro Valente, Marcelo Romero

Abstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

José Vedelago *Instituto de Física Enrique Gaviola (IFEG), CONICET, Córdoba, X5000HUA, Argentina.
Facundo MatteaLaboratorio de Investigación e Instrumentación en Física Aplicada a la Medicina e Imágenes por Rayos X (LIIFAMIRx), FAMAF-UNC, Córdoba, X5000HUA, Argentina.
Sebastián TriviñoLaboratorio de Investigación e Instrumentación en Física Aplicada a la Medicina e Imágenes por Rayos X (LIIFAMIRx), FAMAF-UNC, Córdoba, X5000HUA, Argentina.
María Del Mar MontesinosDepartamento de Bioquímica Clínica, Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI), CONICET, FCQ-UNC, Córdoba, X5000HUA, Argentina.
Walter KeilFCEFyN-UNC & CNEA-Reactor Nuclear RA-0, Córdoba, X5000HUA, Argentina.
Mauro ValenteInstituto de Física Enrique Gaviola (IFEG), CONICET, Córdoba, X5000HUA, Argentina. mauro.valente@gmail.com.
Marcelo Romero *Laboratorio de Investigación e Instrumentación en Física Aplicada a la Medicina e Imágenes por Rayos X (LIIFAMIRx), FAMAF-UNC, Córdoba, X5000HUA, Argentina. marceloricardoromero@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Organoboron compounds have been playing an increasingly important role in analytical chemistry, material science, health applications, and particularly as functional polymers like boron carriers for cancer therapy. There are two main applications of boron isotopes in radiation cancer therapy, Boron Neutron Capture Therapy and Proton Boron Fusion Therapy. In this study, a novel and original material consisting of a three-dimensional polymer network crosslinked with [Formula: see text]B enriched boric acid molecules is proposed and synthesized. The effects of the exposition to thermal neutrons were studied analyzing changes in the mechanical properties of the proposed material. Dedicated Monte Carlo simulations, based on MCNP and FLUKA main codes, were performed to characterize interactions of the proposed material with neutrons, photons, and charged particles typically present in mixed fields in nuclear reactor irradiations. Experimental results and Monte Carlo simulations were in agreement, thus justifying further studies of this promising material.

Indexed as

BoronBoron CompoundsChemical PhenomenaCross-Linking ReagentsDrug CarriersMagnetic Resonance SpectroscopyMolecular StructurePolyaminesPolyhydroxyethyl MethacrylatePolymersRadiation, IonizingBoronBoron CompoundsCross-Linking ReagentsDrug Carrierspoly(2-hydroxyethyl methacrylate)-polyamine graft copolymerPolyaminesPolyhydroxyethyl MethacrylatePolymers

Identifiers

PMID34112821
PMCPMC8192942

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.